On April 2, 2019, LumeN XT welcomed Marc Beer into the position of Chairman of The Board. Marc Beer has over twenty-five years of working experience in the fields of development and advertising. He received this honor for his advancements in minimally invasive surgical procedures and more specifically the illuminating scopes to perform procedures. Using the illumination scope is better to perform surgeries because you can focus on a single area easier, see better, move around easier, and have enhanced accuracy than the previous method of conducting surgery. If needed there is an even more advanced illumination option that offers even more visibility and heat reduction. It may sound expensive, but it is low cost.
Marc Beer also founded a company for women with pelvic floor problems. He founded the company in August of 2016. He is the Chairman and CEO and the name is Renovia Inc. Before he founded Renovia Inc, he founded Minerva Neurosciences Inc. He was the Founding Chairman of Minerva Neurosciences. It specialized in conducting late stage clinical trials and developing therapeutic medications for brain disorders and diseases. Even before his work as the Founding Chairman of Minerva Neuroscience, he worked in many high-pressure situations where he conducted with integrity and poise. He orchestrated many televised commercials in which certain life-threatening diseases were discussed and this educated hundreds on thousands in the process. Also, it has shed light on an unknown, scary and taboo subject that many were ignorant and frightened. His work has saved countless lives.
In April of 2000, Marc Beer started a stem cell banking company called ViaCell in which he was the Founding CEO. This company collected, handled, and stored the umbilical cord stem cells of newborn babies for later use. It took only seven years for the company to go from just a start-up company, to having over 300 employees, to going public, to being bought out by PerkinElmer. Also, while he ran ViaCell he was also on the board at Erytech Pharma. His work for Genzyme is where he was in charge of the commercials for rare diseases.
He also worked in Abbott Laboratories in the sales, marketing, pharmaceutical, and diagnostic departments. Marc Beer is also a former member of the Mass Life Science Board and he also served as a member on the Biotechnology Industry Organization Emerging Companies Section Governing Board. He was also founding chairman for the board of directors and the compensation committee for Good Start Genetics, Inc. Good Start Genetics, Inc recently merged with InVitae. Marc Beer is also a member of the Miami University Business Advisory Council. He was once a member of the Notre Dame Research and Commercialization Advisory Committee and also Notre Dame Graduate Studies Research and Advisory Council. Marc Beer has a bachelors of science degree from Miami University. Learn more: https://www.prnewswire.com/news-releases/lumenxt-names-marc-beer-chairman-of-the-board-300822547.html